ReviewFrontiers in veterinary science2026
The physiologic power of fluid circulation and implications for fluid therapy.
Review in Frontiers in veterinary science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Water is the most prevalent and ubiquitous substance in the body, an essential solvent for all chemical processes and a prerequisite for solute and gas transport. It is reasonable, therefore, that multiple systems and intricate interdependent regulatory mechanisms have evolved to maintain water balance within 1%-2% of body requirements. The overlapping complexity of body fluid regulatory mechanisms provides ample opportunity for healthy animals to tolerate and recover from substantial fluctuations in water volume deficits or excesses, provided that water balance is restored before tissue oxygen and nutrient delivery become irreversibly compromised. Intravenous fluid therapy can restore tissue perfusion in hypovolemic patients, provided the reestablishment of vascular volume and systemic hemodynamic variables are effective in remedying microcirculatory derangements. Inappropriately administered IV fluid, however, results in fluid imbalance, electrolyte and acid-base disorders, fluid accumulation, impaired healing, prolonged recovery, and unfavorable outcomes, especially in patients that are fluid non-responsive or intolerant. Revised and alternative interpretations of circulatory physiology and IV fluid disposition (e.g., volume kinetics) continue to emerge, providing insights on how IV fluids are delivered to avoid adverse effects (e.g., fluid accumulation syndrome) and improve outcomes. Fluid choice, dosage, and the timing of fluid administration are species- and context-dependent and should be individualized based on macro-micro hemodynamic-interstitial-lymphatic concordance, disease-associated changes in fluid disposition, and an understanding of fluid volume kinetics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.